16 research outputs found

    Charge symmetry breaking via rho-omega mixing from model quark-gluon dynamics

    Full text link
    The quark-loop contribution to the ρ0ω\rho^0-\omega mixing self-energy function is calculated using a phenomenologically successful QCD-based model field theory in which the ρ0\rho^0 and ω\omega mesons are composite qˉq\bar{q}q bound states. In this calculation the dressed quark propagator, obtained from a model Dyson-Schwinger equation, is confining. In contrast to previous studies, the meson-qˉq\bar{q}q vertex functions are characterised by a strength and range determined by the dynamics of the model; and the calculated off-mass-shell behaviour of the mixing amplitude includes the contribution from the calculated diagonal meson self-energies. The mixing amplitude is shown to be very sensitive to the small isovector component of dynamical chiral symmetry breaking. The spacelike quark-loop mixing-amplitude generates an insignificant charge symmetry breaking nuclear force.Comment: 11 Pages, 3 figures uuencoded and appended to this file, REVTEX 3.0. ANL-PHY-7718-TH-94, KSUCNR-004-94. [!! PostScript file format corrected. Retrieve by anonymous ftp from theory.phy.anl.gov (130.202.20.190), directory pub: mget wpfig*.ps Three files.

    Tri-meson-mixing of π\pi-η\eta-η\eta' and ρ\rho-ω\omega-ϕ\phi in the light-cone quark model

    Full text link
    The radiative transition form factors of the pseudoscalar mesons {π\pi, η\eta, η\eta'} and the vector mesons {ρ\rho, ω\omega, ϕ\phi} are restudied with π\pi-η\eta-η\eta' and ρ\rho-ω\omega-ϕ\phi in tri-meson-mixing pattern, which is described by tri-mixing matrices in the light-cone constituent quark model. The experimental transition decay widths are better reproduced with tri-meson-mixing than previous results in a two-mixing-angle scenario of only two-meson η\eta-η\eta' mixing and ω\omega-ϕ\phi mixing.Comment: 8 pages, 6 figures, final version to appear in EPJ

    Correlations of some Neoproterozoic carbonate-dominated successions in South America based on high-resolution chemostratigraphy

    No full text

    Implementation of Microbially Safe Foods with Pulsed Electric Fields

    No full text

    Mechanical ventilation in patients with cardiogenic pulmonary edema : a sub-analysis of the LUNG SAFE study

    No full text
    Patients with acute respiratory failure caused by cardiogenic pulmonary edema (CPE) may require mechanical ventilation that can cause further lung damage. Our aim was to determine the impact of ventilatory settings on CPE mortality. Patients from the LUNG SAFE cohort, a multicenter prospective cohort study of patients undergoing mechanical ventilation, were studied. Relationships between ventilatory parameters and outcomes (ICU discharge/hospital mortality) were assessed using latent mixture analysis and a marginal structural model. From 4499 patients, 391 meeting CPE criteria (median age 70 [interquartile range 59-78], 40% female) were included. ICU and hospital mortality were 34% and 40%, respectively. ICU survivors were younger (67 [57-77] vs 74 [64-80] years, p < 0.001) and had lower driving (12 [8-16] vs 15 [11-17] cmHO, p < 0.001), plateau (20 [15-23] vs 22 [19-26] cmHO, p < 0.001) and peak (21 [17-27] vs 26 [20-32] cmHO, p < 0.001) pressures. Latent mixture analysis of patients receiving invasive mechanical ventilation on ICU day 1 revealed a subgroup ventilated with high pressures with lower probability of being discharged alive from the ICU (hazard ratio [HR] 0.79 [95% confidence interval 0.60-1.05], p = 0.103) and increased hospital mortality (HR 1.65 [1.16-2.36], p = 0.005). In a marginal structural model, driving pressures in the first week (HR 1.12 [1.06-1.18], p < 0.001) and tidal volume after day 7 (HR 0.69 [0.52-0.93], p = 0.015) were related to survival. Higher airway pressures in invasively ventilated patients with CPE are related to mortality. These patients may be exposed to an increased risk of ventilator-induced lung injury. Trial registration Clinicaltrials.gov NCT02010073

    Death in hospital following ICU discharge : insights from the LUNG SAFE study

    Get PDF
    Altres ajuts: Italian Ministry of University and Research (MIUR)-Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic); Science Foundation Ireland Future Research Leaders Award; European Society of Intensive Care Medicine (ESICM), Brussels; St Michael's Hospital, Toronto; University of Milan-Bicocca, Monza, Italy.Background: To determine the frequency of, and factors associated with, death in hospital following ICU discharge to the ward. Methods: The Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE study was an international, multicenter, prospective cohort study of patients with severe respiratory failure, conducted across 459 ICUs from 50 countries globally. This study aimed to understand the frequency and factors associated with death in hospital in patients who survived their ICU stay. We examined outcomes in the subpopulation discharged with no limitations of life sustaining treatments ('treatment limitations'), and the subpopulations with treatment limitations. Results: 2186 (94%) patients with no treatment limitations discharged from ICU survived, while 142 (6%) died in hospital. 118 (61%) of patients with treatment limitations survived while 77 (39%) patients died in hospital. Patients without treatment limitations that died in hospital after ICU discharge were older, more likely to have COPD, immunocompromise or chronic renal failure, less likely to have trauma as a risk factor for ARDS. Patients that died post ICU discharge were less likely to receive neuromuscular blockade, or to receive any adjunctive measure, and had a higher pre- ICU discharge non-pulmonary SOFA score. A similar pattern was seen in patients with treatment limitations that died in hospital following ICU discharge. Conclusions: A significant proportion of patients die in hospital following discharge from ICU, with higher mortality in patients with limitations of life-sustaining treatments in place. Non-survivors had higher systemic illness severity scores at ICU discharge than survivors. Trial Registration: ClinicalTrials.gov NCT02010073
    corecore